|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
|
|
|
|||||||||
|
|||||||||||
|
J Am Coll Cardiol, 2002; 40:341-349 © 2002 by the American College of Cardiology Foundation |
* Department of Cardiology, University of Padua Medical School, Padua, Italy
Department of Biology, University of Padua Medical School, Padua, Italy
Department of Pathology, University of Padua Medical School, Padua, Italy
Manuscript received November 13, 2001; revised manuscript received April 1, 2002, accepted April 19, 2002.
* Reprint requests and correspondence: Andrea Nava, MD, c/o Associazione Ricerche Cardiopatie Aritmiche, Via A. Gabelli, 86-35121, Padua, Italy.
andrea.nava{at}unipd.it
OBJECTIVES: We sought to establish the role of genetic screening for ryanodine receptor type 2 (RyR2) gene mutations in families with effort-induced polymorphic ventricular arrhythmia (PVA), syncope and juvenile sudden death.
BACKGROUND: The RyR2 mutations have been associated with PVA, syncope and sudden death in response to physical or emotional stress.
METHODS: We studied 81 subjects (39 males and 42 females; mean age 31 ± 20 years) belonging to eight families with pathogenic RyR2 mutations. All subjects underwent screening for RyR2 mutations, electrocardiography (ECG), 24-h Holter monitoring, signal-averaged electrocardiography (SAECG), two-dimensional echocardiography and exercise stress testing. Electrophysiologic (EP) study was performed in nine patients.
RESULTS: Six different RyR2 mutations were found in eight families. Forty-three family members carried the gene mutation. Of these, 28 (65%) showed effort-induced arrhythmic symptoms or signs and one died suddenly during follow-up. Family history revealed 19 juvenile cases of sudden death during effort or emotion. In two families sharing the same mutation, no subject presented with PVA during the stress test; thus, sudden death and syncope were the only clinical manifestations. The 12-lead ECG was normal in all but two subjects, whereas five patients showed positive late potentials on the SAECG. In 17 (39.5%) of 43 subjects, the two-dimensional echocardiogram revealed localized kinetic abnormalities and mild structural alterations of the right ventricle. The EP study was not able to induce PVA.
CONCLUSIONS: The absence of symptoms and PVA on the stress test in more than one-third of carriers of RyR2 mutations, as well as the lack of PVA inducibility by the EP study, underlies the importance of genetic screening for the early diagnosis of asymptomatic carriers and prevention of sudden death.
| ||||||||||||||||||||
This article has been cited by other articles:
|
|
 |
|
  H. E. D. J. ter Keurs and P. A. Boyden Calcium and Arrhythmogenesis Physiol Rev, April 1, 2007; 87(2): 457 - 506. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Iyer, R. J. Hajjar, and A. A. Armoundas Mechanisms of Abnormal Calcium Homeostasis in Mutations Responsible for Catecholaminergic Polymorphic Ventricular Tachycardia Circ. Res., February 2, 2007; 100(2): e22 - e31. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Kannankeril, B. M. Mitchell, S. A. Goonasekera, M. G. Chelu, W. Zhang, S. Sood, D. L. Kearney, C. I. Danila, M. De Biasi, X. H. T. Wehrens, et al. Mice with the R176Q cardiac ryanodine receptor mutation exhibit catecholamine-induced ventricular tachycardia and cardiomyopathy PNAS, August 8, 2006; 103(32): 12179 - 12184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Dalal, L. H. Molin, J. Piccini, C. Tichnell, C. James, C. Bomma, K. Prakasa, J. A. Towbin, F. I. Marcus, P. J. Spevak, et al. Clinical Features of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Associated With Mutations in Plakophilin-2 Circulation, April 4, 2006; 113(13): 1641 - 1649. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Creighton, R. Virmani, R. Kutys, and A. Burke Identification of Novel Missense Mutations of Cardiac Ryanodine Receptor Gene in Exercise-Induced Sudden Death at Autopsy J. Mol. Diagn., February 1, 2006; 8(1): 62 - 67. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Syrris, D. Ward, A. Asimaki, S. Sen-Chowdhry, H. Y. Ebrahim, A. Evans, N. Hitomi, M. Norman, A. Pantazis, A. L. Shaw, et al. Clinical Expression of Plakophilin-2 Mutations in Familial Arrhythmogenic Right Ventricular Cardiomyopathy Circulation, January 24, 2006; 113(3): 356 - 364. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. H. George, H. Jundi, N. Walters, N. L. Thomas, R. R. West, and F. A. Lai Arrhythmogenic Mutation-Linked Defects in Ryanodine Receptor Autoregulation Reveal a Novel Mechanism of Ca2+ Release Channel Dysfunction Circ. Res., January 6, 2006; 98(1): 88 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Liu, R. Wang, J. Zhang, S. R. W. Chen, and T. Wagenknecht Localization of a Disease-associated Mutation Site in the Three-dimensional Structure of the Cardiac Muscle Ryanodine Receptor J. Biol. Chem., November 11, 2005; 280(45): 37941 - 37947. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A V Postma, I Denjoy, J Kamblock, M Alders, J-M Lupoglazoff, G Vaksmann, L Dubosq-Bidot, P Sebillon, M M A M Mannens, P Guicheney, et al. Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients J. Med. Genet., November 1, 2005; 42(11): 863 - 870. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kontula, P. J. Laitinen, A. Lehtonen, L. Toivonen, M. Viitasalo, and H. Swan Catecholaminergic polymorphic ventricular tachycardia: Recent mechanistic insights Cardiovasc Res, August 15, 2005; 67(3): 379 - 387. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. T. Beery The Genetics of Cardiac Arrhythmias Biol Res Nurs, April 1, 2005; 6(4): 249 - 261. [Abstract] [PDF]
|
|
|
|
|
|
G. Choi, L. J. Kopplin, D. J. Tester, M. L. Will, C. M. Haglund, and M. J. Ackerman Spectrum and Frequency of Cardiac Channel Defects in Swimming-Triggered Arrhythmia Syndromes Circulation, October 12, 2004; 110(15): 2119 - 2124. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. I. Khalil, A. Kamal, and S. Ahmad Arrhythmogenic right ventricular dysplasia presenting as acute coronary syndrome: a case report Eur J Echocardiogr, October 1, 2004; 5(5): 394 - 398. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bagattin, C. Veronese, B. Bauce, W. Wuyts, L. Settimo, A. Nava, A. Rampazzo, and G. A. Danieli Denaturing HPLC-Based Approach for Detecting RYR2 Mutations Involved in Malignant Arrhythmias Clin. Chem., July 1, 2004; 50(7): 1148 - 1155. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Basso, T. Wichter, G. A Danieli, D. Corrado, E. Czarnowska, G. Fontaine, W. J McKenna, A. Nava, N. Protonotarios, L. Antoniades, et al. Arrhythmogenic right ventricular cardiomyopathy: clinical registry and database, evaluation of therapies, pathology registry, DNA banking Eur. Heart J., March 2, 2004; 25(6): 531 - 534. [Full Text] [PDF]
|
|
|
|
|
|
S. G. Priori Inherited Arrhythmogenic Diseases: The Complexity Beyond Monogenic Disorders Circ. Res., February 6, 2004; 94(2): 140 - 145. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. V. Postma, I. Denjoy, T. M. Hoorntje, J.-M. Lupoglazoff, A. Da Costa, P. Sebillon, M. M.A.M. Mannens, A. A.M. Wilde, and P. Guicheney Absence of Calsequestrin 2 Causes Severe Forms of Catecholaminergic Polymorphic Ventricular Tachycardia Circ. Res., October 18, 2002; 91 (8): e21 - e26. [Abstract] [Full Text] [PDF]
|
|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
